Robert Zangerle

2.5k total citations
15 papers, 153 citations indexed

About

Robert Zangerle is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Robert Zangerle has authored 15 papers receiving a total of 153 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 7 papers in Virology and 6 papers in Epidemiology. Recurrent topics in Robert Zangerle's work include HIV Research and Treatment (7 papers), HIV/AIDS Research and Interventions (4 papers) and HIV, Drug Use, Sexual Risk (4 papers). Robert Zangerle is often cited by papers focused on HIV Research and Treatment (7 papers), HIV/AIDS Research and Interventions (4 papers) and HIV, Drug Use, Sexual Risk (4 papers). Robert Zangerle collaborates with scholars based in Austria, Netherlands and United Kingdom. Robert Zangerle's co-authors include F Gerstenbrand, Peter Pohl, Roy Robertson, David Goldberg, Nicolas Carré, Ildefonso Hernández‐Aguado, Maria Prins, Marion Cornelissen, Jim McMenamin and Maria Prins and has published in prestigious journals such as International Journal of Epidemiology, AIDS and JAIDS Journal of Acquired Immune Deficiency Syndromes.

In The Last Decade

Robert Zangerle

13 papers receiving 148 citations

Peers

Robert Zangerle
Margaret Camarca United States
Robert Zangerle
Citations per year, relative to Robert Zangerle Robert Zangerle (= 1×) peers Margaret Camarca

Countries citing papers authored by Robert Zangerle

Since Specialization
Citations

This map shows the geographic impact of Robert Zangerle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Zangerle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Zangerle more than expected).

Fields of papers citing papers by Robert Zangerle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Zangerle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Zangerle. The network helps show where Robert Zangerle may publish in the future.

Co-authorship network of co-authors of Robert Zangerle

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Zangerle. A scholar is included among the top collaborators of Robert Zangerle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Zangerle. Robert Zangerle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Trickey, Adam, Ard van Sighem, John Stover, et al.. (2019). Parameter estimates for trends and patterns of excess mortality among persons on antiretroviral therapy in high-income European settings. AIDS. 33(Supplement 3). S271–S281. 4 indexed citations
2.
Zangerle, Robert & Peter Fritsch. (2015). Candidiasis and the Immunodeficient Host: An Update. Current problems in dermatology. 18. 185–192.
3.
Smit, Colette, Joop E. Arends, Lars Peters, et al.. (2015). Effect of abacavir on sustained virologic response to HCV treatment in HIV/HCV co-infected patients, Cohere in Eurocoord. BMC Infectious Diseases. 15(1). 498–498. 2 indexed citations
4.
Taylor, Ninon, Jan Marco Kern, Alois Lang, et al.. (2014). Human immunodeficiency virus type 2 infections in Austria. Wiener klinische Wochenschrift. 126(7-8). 212–216. 1 indexed citations
5.
Olson, Ashley, Marguerite Guiguet, Robert Zangerle, et al.. (2014). Evaluation of Rapid Progressors in HIV Infection as an Extreme Phenotype. JAIDS Journal of Acquired Immune Deficiency Syndromes. 67(1). 15–21. 17 indexed citations
6.
Curno, Mirjam, et al.. (2011). Absence of evidence is not evidence of absence: encouraging gender analyses in scholarly publications. 5 indexed citations
7.
Coul, Eline Op de, M. Prins, Marion Cornelissen, et al.. (2001). Using phylogenetic analysis to trace HIV-1 migration among western European injecting drug users seroconverting from 1984 to 1997. AIDS. 15(2). 257–266. 27 indexed citations
8.
Prins, Maria, R.P. Brettle, Roy Robertson, et al.. (1999). Geographical variation in disease progression in HIV-1 seroconverted injecting drug users in Europe?. International Journal of Epidemiology. 28(3). 541–549. 15 indexed citations
9.
Carré, Nicolas, Maria Prins, Laurence Meyer, et al.. (1997). Has the rate of progression to AIDS changed in recent years?. AIDS. 11(13). 1611–1618. 21 indexed citations
10.
Zangerle, Robert, Mario Sarcletti, Harald Gallati, et al.. (1994). Correlation of Body Mass Index with Urinary Neopterin in Individuals Infected with Human Immunodeficiency Virus. International Archives of Allergy and Immunology. 104(2). 150–154. 8 indexed citations
11.
Fuchs, Dietmar, et al.. (1994). Neopterin and HIV infection.. PubMed. 41 Suppl. 21–5.
12.
Pohl, Peter C., et al.. (1992). Double-tracer SPECT in patients with AIDS encephalopathy:. Nuclear Medicine Communications. 13(8). 586–592. 3 indexed citations
13.
Zangerle, Robert, Peter Fritsch, Dietmar Fuchs, & H. Wächter. (1990). Is Neopterin Helpful in Distinguishing between Different Disease Patterns in AIDS?. Pteridines. 2(2). 87–89. 2 indexed citations
14.
Puelacher, Wolfgang, et al.. (1989). [Oral manifestations of HIV infection].. PubMed. 86(8). 539–48. 5 indexed citations
15.
Pohl, Peter, et al.. (1988). Single photon emission computed tomography in AIDS dementia complex.. PubMed. 29(8). 1382–6. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026